Vultures are circling over troubled businesses, but will they make a killing?
Andrew Bevin
Andrew Bevin is an Auckland-based business reporter who covers major industries, markets, regulation, aged care and fisheries.
Posted inNews
Auckland Airport sale blazes trail for Wellington
Wellington City Council votes to explore selling its 34 percent stake in Wellington International Airport
Posted inBusiness
NZ Post buying major parcel competitor
A complaint has already been fired off to the ComCom against the purchase of PBT
Posted inBusiness
Hauraki Gulf kingfish farm clears final regulatory hurdle
The iwi-owned aquaculture facility will cover nearly 300 hectares between Coromandel and Waiheke
Posted inBusiness
Detroit union success lays path for New Zealand
Repealing fair pay agreements will give rise to more difficult forms of collective bargaining
Posted inBusiness
Financial mentors plead against softer lending regulations
The incoming government plans to do away with parts of the Consumer Finance Act it believes are stifling access to credit
Posted inBusiness
Government grabs more power in Ruapehu liquidation
MBIE has appointed receivers from Calibre Partners to advance a sale of the ski fields
Posted inBusiness
Breaking the supermarket chilled logistics chokehold
Access to a cold transport network and warehousing is an expensive barrier to grocery competition
Posted inHealth & Science
NZ farmers help antibiotic resistance fight – but human case is being lost
Agriculture is making an admirable effort towards fighting antibiotic resistance and academics want doctors to do the same
Posted inBusiness
NZ's oldest fuel brand closes stores and goes budget
The owner of Z and Caltex is prioritising a clear differential between the brands
Posted inBusiness
Owner of troubled Sara Lee bidding for Whakapapa
The dessert company's owner says its administration won't affect its bid to buy the North Island ski-field
Posted inCorporate, Government, Health & Science, News, Newsroom Pro
Medsafe overrides its Medicines Classification Committee on cannabis
The Medicines Classification Committee advised against over-the-counter CBD sales
